AI researcher ‘turns down $1bn pay offer from Mark Zuckerberg'
Mr Zuckerberg's Meta reportedly offered several researchers who work at Thinking Machines, a San Francisco-based AI start-up, packages worth hundreds of millions of dollars to join the social media giant.
One of those packages would have been worth as much as $1bn over several years, according to a report from Wired, while some researchers were also offered between $200m and $500m over a four-year period. Most deals included an award worth $50m to $100m in the first year.
So far, no staff at the start-up have taken up an offer from Meta. Last month, Thinking Machines raised $2bn at a $12bn valuation, despite having no product.
A spokesman for Meta disputed the claims, although confirmed it had made a 'handful' of offers to staff at Thinking Machines.
'We made offers only to a handful of people at Thinking Machines and while there was one sizeable offer, the details are off,' the spokesman said.
Thinking Machines was founded by 36-year-old Mira Murati, a former OpenAI executive who has become one of the powerful women in tech since launching the company.
AI arms race
The eye-watering pay offers come amid an AI arms race, with tech giants trying to tempt leading AI scientists and programmers to join their efforts over those of rivals.
Sam Altman, the chief executive of OpenAI which owns ChatGPT, previously claimed Meta had offered his staff deals worth as much as $100m.
Mr Zuckerberg has been personally leading a recruitment drive to attract leading scientists and developers to a new lab within Meta in a race against rivals to build highly powerful AI tools.
The Meta chief executive has reportedly been reaching out to dozens of targets with personalised WhatsApp messages and bumper pay deals.
Meta is spending tens of billions of dollars on AI data centres that will be used to help create more powerful machine-learning tools that Mr Zuckerberg has claimed could soon transform the economy and society.
He has also already recruited around 50 leading researchers and experts for a new 'superintelligence' lab within Meta, after growing frustrated at the lack of progress by his own engineers.
Earlier this year, Meta delayed a major update to its AI technology, dubbed Behemoth.
Mr Zuckerberg also engineered a $14.3bn deal to poach Alexandr Wang, the founder of AI business Scale AI, to lead his new team, acquiring a 49pc stake in the start-up in the process.
Se produjo un error al recuperar la información
Inicia sesión para acceder a tu portafolio
Se produjo un error al recuperar la información
Se produjo un error al recuperar la información
Se produjo un error al recuperar la información
Se produjo un error al recuperar la información
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
International Flavors and Fragrances beats quarterly revenue, profit estimates
(Reuters) -International Flavors and Fragrances topped Wall Street estimates for second-quarter revenue and profit on Tuesday, driven by resilient demand, higher prices and a shift to better-margin businesses. The company has streamlined its portfolio as choppy demand in some food and beauty markets forced its customers to hold leaner inventories. On Tuesday, the company, which disposed of its pharma solutions business earlier this year, said it would sell its soy crush, concentrates, and lecithin unit to U.S. grain trader and processor Bunge Global. IFF did not disclose financial terms but said the operations generated about $240 million in revenue in 2024. The company posted net sales of $2.76 billion for the quarter ended June 30, beating estimates of $2.70 billion, according to data compiled by LSEG. Its adjusted profit of $1.15 per share also topped expectations of $1.12. Advance purchases by packaged food and beauty companies looking to beat higher prices due to tariffs also boosted sales at IFF in the reported quarter. "We remain on track to deliver our 2025 commitments we outlined earlier this year, even as the operating environment has become more challenging," said CEO Erik Fyrwald. IFF's shares were up nearly 5% in extended trading. They have fallen about 16% so far this year. The New York-headquartered company maintained its annual sales and adjusted core profit targets. The company also said it authorized a new share buyback program with a total value of $500 million. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16 minutes ago
- Yahoo
Long-Term Unemployment Rises In Worrying Sign For U.S. Labor Market
WASHINGTON – Signals of labor market weakness go beyond the headline numbers that prompted President Donald Trump to fire the government's head statistician last week. The jobs report released Friday showed a slowdown in hiring, a slight uptick in the national unemployment rate, and a few other clues that the economy is softening — including an increase in long-term unemployment. The number of people jobless for six months or more increased from 1.6 million to 1.8 million in July, representing 24% of the unemployed. It's the most people experiencing long-term joblessness since the end of 2021 and the highest percentage since February 2022, when the economy was still recovering from coronavirus lockdowns. Valerie Wilson, a labor economist at the liberal Economic Policy Institute, said the modest rise in long-term joblessness could reflect employers getting pickier about hiring as President Donald Trump's tariff regime changes the cost of doing business. 'People who have been unemployed for longer have clearly had some challenges in getting back into the labor market,' Wilson told HuffPost. 'I think that as things have softened, and employers are facing more uncertainty given the sort of chaotic nature of economic policy in this country, that it would be harder for those people to find new jobs.' The president's tariffs on goods imported from other countries are tantamount to a $1,219 tax increase on American households this year, according to an estimate by the conservative Tax Foundation. HuffPost readers: Dealing with long-term unemployment? Tell us about it – email arthur@ Please include your phone number if you're willing to be interviewed. Persistently high long-term joblessness was a hallmark of slow recovery from the Great Recession that officially ended in 2009. It disproportionately affected older workers, becoming a self-perpetuating problem as employers sought job applicants with minimal or no gaps on their resumes. Some economists worry another recession could be around the corner. The overall unemployment rate remained low in July, at just 4.2%, and the economy has continued to add jobs, albeit at a slower pace than previously estimated. Bureau of Labor Statistics data suggest the last three months were the weakest for job growth since the pandemic. Trump fired the BLS commissioner on Friday, claiming without evidence that the numbers were somehow 'rigged' to make him look bad. The labor force shrank slightly in July, helping hold down the unemployment rate even as the number of employed workers declined. Wilson noted the unemployment rate for Black Americans rose to 7.2%, up from a recent historical low of 4.8% in April 2023. 'Over the last two months, we're seeing the black unemployment rate pick up, which is another one that as that starts to rise, we start to look for signals of a broader slowing in the economy,' Wilson said.
Yahoo
16 minutes ago
- Yahoo
Fortrea Appoints Tracy Krumme as Senior Vice President, Investor Relations
DURHAM, N.C., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the appointment of Tracy Krumme as senior vice president, investor relations, succeeding Hima Inguva in this role, who has decided to pursue other career opportunities. Krumme will report to Chief Financial Officer, Jill McConnell, and lead Fortrea's global investor relations strategy, serving as a key liaison to the investment community. 'Tracy is a seasoned executive with the strategic mindset and investor acumen needed as Fortrea enters its next chapter,' said McConnell. 'She brings not only deep capital markets expertise but also integrity, insight and a strong track record of supporting strategic transformation and growth. We're excited to welcome her to the team. I also would like to express my sincere appreciation to Hima Inguva, who has led Fortrea's Investor Relations since our founding as a company. We wish her every success in her next chapter.' Krumme brings more than three decades of investor relations and capital markets experience to Fortrea, with expertise across the CRO, life sciences and healthcare sectors. She previously served as head of investor relations at PPD, a leading CRO acquired by Thermo Fisher Scientific, where she worked alongside Fortrea's CEO Anshul Thakral; Galderma, a global dermatology company; and Nuance Communications, a provider of healthcare AI solutions acquired by Microsoft. Most recently, she was senior vice president, head of investor relations and corporate communications at Bitfarms, a global energy and compute infrastructure company. Earlier in her career, she led investor relations at Luxoft, acquired by DXC Technology, and NCR Corporation, and held roles as an equity research analyst at Sandler O'Neill & Partners and in corporate finance at Prudential Securities and Kidder, Peabody International in London. 'I'm excited to join Fortrea at such a pivotal moment in its evolution as an independent, pure-play CRO,' said Krumme. 'I look forward to working with the leadership team to articulate Fortrea's vision and value proposition to the investment community as we deliver differentiated solutions to our customers and generate long-term value for shareholders.' About Fortrea Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea's solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at and follow us on LinkedIn and X (formerly Twitter). Fortrea Contacts: Tracy Krumme (Investors) – 984-385-6707, Inguva (Investors) – 877-495-0816, Sue Zaranek (Media) – 919-943-5422, media@ Kate Dillon (Media) – 646-818-9115, kdillon@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
